Showing 41 - 60 results of 64 for search '"HPV vaccine"', query time: 0.07s Refine Results
  1. 41

    Factors Associated With Adolescents' Human Papillomavirus Vaccination Intention: A Cross‐Sectional Survey by Angela Chia‐Chen Chen, ChengChing Hiya Liu, Kimberly Arcoleo, Jiying Ling, Lorraine B. Robbins

    Published 2024-12-01
    “…ABSTRACT Aim To examine relationships between hypothesized potential predictors of vaccination and adolescent's Human papillomavirus (HPV) vaccination intention and whether these predictors differed by sex. …”
    Get full text
    Article
  2. 42

    Comparison of Self-Efficacy and Knowledge of Human Papillomavirus Vaccination among Various Types of Decision Makers in Indonesia: A Cross-Sectional Study by Dora Samaria, Eva Tallutondok, Chandrayani Simanjorang, Imanuel Imanuel

    Published 2025-01-01
    “…Background: Self-efficacy and knowledge of various types of decision-makers concerning the Human Papillomavirus (HPV) vaccine can play an essential role in the acceptance of the vaccine in women. …”
    Get full text
    Article
  3. 43

    Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization by Bahareh Bahmani, Zahra Amini-bayat, Mohammad Mehdi Ranjbar, Masoud Hassanzadeh Makoui, Amir-Hassan Zarnani

    Published 2025-02-01
    “…Conclusion The poly-epitope vaccine for HPV16-E7, as expressed and purified in this research, is highly immunogenic and capable of triggering E7-specific antibodies, making it a potential therapeutic HPV vaccine. Further research is needed to optimize the vaccination schedule and assess the E7-specific immune cell profile.…”
    Get full text
    Article
  4. 44

    Public Health Ethics and Practice /

    Published 2010
    Table of Contents: “…/ Jessica Datta and Anthony Kessell -- Constructing the obesity epidemic: loose science, money and public health / Alison Hann and Stephen Peckham -- Politics, ethics and evidence: immunisation and public health policy / Alison Hann and Stephen Peckham -- Avoiding mixed messages: HPV vaccines and the 'cure' for cervical cancer / Alison Hann and Stephen Peckham -- A call for clearer vaccine exemption typology to improve population health / Erica Sutton and Ross Upshur -- PART THREE. …”
    View in OPAC
    Book
  5. 45

    Knowledge, attitude, and reasons for non-uptake of human papilloma virus vaccination among nursing students by Soni Chauhan, Surya Kant Tiwari, Vishal Dubey, Pragya Tripathi, Priyanka Pandey, Anuj Singh, Narendra Pal Singh Choudhary

    Published 2025-01-01
    “…The Human papillomavirus (HPV) vaccination, a vital preventive measure, has suboptimal uptake among nursing students. …”
    Get full text
    Article
  6. 46

    Outcomes of Human Papilloma Virus Vaccination in a Private Women Health Clinic in Lebanon by Muhieddine Seoud, Iman Jaafar, Rayan Ghanem, Christiane Soubhieh, Abdallah Adra, Anwar Nassar, Ali Khalil

    Published 2022-01-01
    “…Methods. Opportunistic HPV vaccination is offered at the Women’s Health Center of the AUBMC. …”
    Get full text
    Article
  7. 47

    A male-female mathematical model of human papillomavirus (HPV) in African American population by Najat Ziyadi

    Published 2016-12-01
    “…We compute the basic reproduction number, $\mathcal{R}_0$ , and use it to show that $\mathcal{R}_0$ is less than 1 in the African American (AA) population with or without implementation of HPV vaccination program. Furthermore, we obtain that adopting a HPV vaccination policy in the AAF and AAM populations lower $\mathcal{R}_0$ and the number of HPV infections. …”
    Get full text
    Article
  8. 48

    Knowledge and attitude among Egyptian medical students regarding the role of human papillomavirus vaccine in prevention of oropharyngeal cancer: a questionnaire-based observational... by Mohammed. N. Abdelaziz, Abdullah Hefnawy, Hajer Azzam, Omar Reisha, Omar Hamdy

    Published 2025-01-01
    “…Still, political will, inadequate financing, and inadequate infrastructure help to explain the slow dissemination of anti-HPV vaccination. This study sought to evaluate Egyptian medical students’ knowledge, awareness, and attitude toward the advantages of HPV vaccination to prevent HPV-associated OPC. …”
    Get full text
    Article
  9. 49
  10. 50

    Costs and Resource Use Among Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Genital Warts in Algeria by Ali-Chakib Bennacef, Aomar Ammar Khodja, Fadl Allah Abou-Bekr, Tidiane Ndao, Ryan Holl, Goran Benčina

    Published 2022-02-01
    “…**Background:** Cervical cancer rates in North Africa have risen in the last 10 years, suggesting that this region might benefit from cervical cancer screening and HPV vaccination programs. To assess the potential benefits of cervical cancer screening and HPV vaccination in North African countries, country-specific data on the prevalence and burden of HPV-related conditions are needed. …”
    Get full text
    Article
  11. 51

    Global cervical cancer elimination: quantifying the status, progress, and gaps by Liangru Zhou, Yi Li, Hongyun Wang, Ruixi Qin, Zhen Han, Ruifeng Li

    Published 2025-02-01
    “…A total of 115 countries (51 (44.35%) HICs and 64 (55.65%) LMICs)) included HPV vaccination in their national immunisation programs. …”
    Get full text
    Article
  12. 52

    Cervical cancer screening by cotesting method for Vietnamese women 25–55 years old: a cost-effectiveness analysis by Hien Thu Bui, Van Nu Hanh Pham, Thang Hong Vu

    Published 2025-01-01
    “…However, CC remains a significant public health issue in low-income and middle-income countries (LMICs) like Vietnam, where financial constraints hinder the widespread implementation of HPV vaccination and screening programmes. Currently, Vietnam lacks both a national CC screening intervention and an HPV vaccination programme for women and girls. …”
    Get full text
    Article
  13. 53

    cGAS/STING signaling pathway in gynecological malignancies: From molecular mechanisms to therapeutic values by Danyang Zhang, Bingxue Zhang

    Published 2025-01-01
    “…Gynecological cancers, including cervical, ovarian, and endometrial malignancies, remain a significant global health burden, exacerbated by disparities in access to preventive measures such as HPV vaccination and routine screening. The cGAS/STING signaling pathway, a pivotal mechanism in innate immunity, detects cytosolic DNA from pathogens or cellular damage, triggering immune responses via type I interferons and inflammatory cytokines. …”
    Get full text
    Article
  14. 54

    Tingkat Pengetahuan, Sikap dan Perilaku Mahasiswi Fakultas Kedokteran Universitas Sumatera Utara Tentang Kanker Serviks by Savira Laniari Putri, Feby Yanti Harahap

    Published 2022-07-01
    “…It can be prevented by HPV vaccination, pap smears examination, or avoidance of risk factors for cervical cancer. …”
    Get full text
    Article
  15. 55

    Knowledge, Attitude, And Practices of The Educated Women of North India Toward Cervical Cancer by Ishita Miglani, Urvashi Gandhi, Poonam Laul

    Published 2025-01-01
    “…Girls and women aged 15 years and more studying in educational institutions or those who have completed their graduation were asked to fill out the questionnaire if willing to do so anonymously. 824 respondents filled out the online survey. 75% of the respondents had good knowledge about pap smear and HPV vaccination. Only 80 respondents (9.7%) were vaccinated against HPV. 255 (30.9%) had been screened with a pap smear at least once in their lifetime. …”
    Get full text
    Article
  16. 56

    Investigating new drugs from marine seaweed metabolites for cervical cancer therapy by molecular dynamic modeling approach by Sk Injamamul Islam, Sheikh Sunzid Ahmed, Sarower Mahfuj, Gunjan Das, Md. Mohaimenul Islam Tareq, Mazen Almehmadi, Mamdouh Allahyani, Naif Alsiwiehri, Partha Biswas, Md. Nazmul Hasan, Foysal Ahammad

    Published 2025-01-01
    “…The high costs and side effects of standard treatments and the limited efficacy of HPV vaccination have led to a quest for novel, cost-effective cervical cancer treatments, particularly in middle- and low-income countries. …”
    Get full text
    Article
  17. 57

    Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents by Don E. Willis, Marie‐Rachelle Narcisse, Laura James, James P. Selig, Mohammed Ason, Aaron J. Scott, Lawrence E. Cornett, Pearl A. McElfish

    Published 2025-01-01
    “…In this study, we asked: What latent classes of vaccine hesitancy might exist when examining parents' attitudes toward vaccines in general and COVID‐19 and human papillomavirus (HPV) vaccination specifically? Which sociodemographic, health access, and health‐related variables are predictive of membership in those classes? …”
    Get full text
    Article
  18. 58

    Study of the Prevalence of Human Papillomavirus Genotypes in Jeddah, Saudi Arabia by Mai M. El-Daly, Arwa A. Faizo, Shahad A. Madkhali, Nashwa F. Aldardeir, Nassrin A. Badroon, Norah A. Uthman, Rahaf T. Alqawas, Ahmed A. Mousa, Safaa A. Turkistani, Esam I. Azhar

    Published 2025-01-01
    “…This study emphasizes the importance of HPV vaccination programs, increased screening, and educational campaigns to address the high prevalence of high-risk genotypes, particularly HPV 16. …”
    Get full text
    Article
  19. 59

    Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months by Brenda Asiimwe-Kateera, Nienke Veldhuijzen, Jean Paul Balinda, John Rusine, Sally Eagle, Joseph Vyankandondera, Julie Mugabekazi, Pascale Ondoa, Kimberly Boer, Anita Asiimwe, Joep Lange, Peter Reiss, Janneke van de Wijgert

    Published 2015-01-01
    “…We applaud the Rwandan government for having strengthened family planning and PMTCT services and for having introduced HPV vaccination in recent years, but additional work is needed to strengthen STI and HPV-related cancer screening and management in the HIV-positive population.…”
    Get full text
    Article
  20. 60

    Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites by Ciying Qian, Jie Chen, Yurou Yang, Yihan Lu, Tianyu Ren, Yanan Jiang, Yang Huang, Xin Chi, Shuyue Zhang, Chengzong Zhang, Kewei Li, Jingjia Shen, Sibo Zhang, Daning Wang, Lizhi Zhou, Tingting Li, Qingbing Zheng, Hai Yu, Ying Gu, Ningshao Xia, Shaowei Li

    Published 2025-01-01
    “…Abstract The numerous high-risk carcinogenic types of human papillomavirus (HR-HPV) that lack vaccine protection underscore the urgent need to develop broader-spectrum HPV vaccines. This study addresses this need by focusing on HR-HPV types 53, 56, and 66, which are not currently targeted by existing vaccines. …”
    Get full text
    Article